{"id":571,"date":"2022-12-11T07:11:00","date_gmt":"2022-12-11T07:11:00","guid":{"rendered":"https:\/\/www.junshipharma.com\/%e5%90%9b%e5%af%a6%e7%94%9f%e7%89%a9%e5%9c%a8%e9%a6%99%e6%b8%af%e8%81%af%e4%ba%a4%e6%89%80%e4%b8%bb%e6%a9%9f%e6%9d%bf%e6%88%90%e5%8a%9f%e4%b8%8a%e5%b8%82\/"},"modified":"2023-05-04T10:30:14","modified_gmt":"2023-05-04T10:30:14","slug":"%e5%90%9b%e5%af%a6%e7%94%9f%e7%89%a9%e5%9c%a8%e7%ac%ac64%e5%b1%86%e7%be%8e%e5%9c%8b%e8%a1%80%e6%b6%b2%e5%ad%b8%e6%9c%83%ef%bc%88ash%ef%bc%89%e5%b9%b4%e6%9c%83%e5%85%ac%e4%bd%88%e6%8a%97btla%e5%96%ae","status":"publish","type":"post","link":"https:\/\/www.junshipharma.com\/zh-hant\/%e5%90%9b%e5%af%a6%e7%94%9f%e7%89%a9%e5%9c%a8%e7%ac%ac64%e5%b1%86%e7%be%8e%e5%9c%8b%e8%a1%80%e6%b6%b2%e5%ad%b8%e6%9c%83%ef%bc%88ash%ef%bc%89%e5%b9%b4%e6%9c%83%e5%85%ac%e4%bd%88%e6%8a%97btla%e5%96%ae\/","title":{"rendered":"\u541b\u5be6\u751f\u7269\u5728\u7b2c64\u5c46\u7f8e\u570b\u8840\u6db2\u5b78\u6703\uff08ASH\uff09\u5e74\u6703\u516c\u4f48\u6297BTLA\u55ae\u6297tifcemalimab\u6cbb\u7642\u5fa9\u767c\u6216\u96e3\u6cbb\u6027\u6dcb\u5df4\u7624\u7684\u7814\u7a76\u7d50\u679c"},"content":{"rendered":"\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
\u5317\u4eac\u6642\u95932022\u5e7412\u670811\u65e5\uff0c\u541b\u5be6\u751f\u7269\uff081877.HK\uff0c688180.SH\uff09\u5ba3\u4f48\uff0c\u7531\u516c\u53f8\u81ea\u4e3b\u7814\u767c\u7684\u5168\u7403\u9996\u500b\u9032\u5165\u81e8\u5e8a\u968e\u6bb5\u7684\u6297\u816b\u7624\u6297BTLA\u55ae\u6297tifcemalimab\uff08TAB004\/JS004\uff09\u57282022\u5e74\u7b2c64\u5c46\u7f8e\u570b\u8840\u6db2\u5b78\u6703\uff08ASH\uff09\u5e74\u6703\u4e0a\u4ee5\u58c1\u5831\u5f62\u5f0f\uff08#1613\uff09\u66f4\u65b0\u4e86\u5176\u5728\u5fa9\u767c\u6216\u96e3\u6cbb\u6027\u6dcb\u5df4\u7624\u60a3\u8005\u4e2d\u9032\u884c\u7684I\u671f\u81e8\u5e8a\u8a66\u9a57\u521d\u6b65\u8cc7\u6599\u3002<\/p>\n\n\n\n
\u5317\u4eac\u5927\u5b78\u816b\u7624\u91ab\u9662\u7684\u5b8b\u7389\u7434\u6559\u6388<\/strong>\u8868\u793a\uff1a\u201c\u5982\u4eca\uff0cPD-1\u6291\u5236\u5291\u5df2\u5ee3\u6cdb\u61c9\u7528\u5728\u6dcb\u5df4\u7624\u5c24\u5176\u662f\u5fa9\u767c\u6216\u96e3\u6cbb\u6027\u7d93\u5178\u578b\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08R\/R cHL\uff09\u6cbb\u7642\u9818\u57df\uff0c\u7136\u800c\u4e00\u65e6\u5931\u6557\u4fbf\u7121\u6a19\u6e96\u6cbb\u7642\uff0c\u81e8\u5e8a\u4e9f\u9700\u65b0\u7684\u6cbb\u7642\u624b\u6bb5\u3002\u901a\u904e\u7814\u7a76\uff0c\u6211\u5011\u767c\u73fe\u9019\u985e\u60a3\u8005\u5728\u63a5\u53d7tifcemalimab\u8207\u7279\u745e\u666e\u5229\u55ae\u6297\u806f\u5408\u6cbb\u7642\u5f8c\u6709\u671b\u518d\u6b21\u7372\u76ca\uff0c\u4e26\u4e14\u4e5f\u89c0\u5bdf\u5230\u9019\u4e00\u7642\u6cd5\u8207\u5176\u4ed6\u514d\u75ab\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u7684\u985e\u4f3c\u4e4b\u8655\uff0c\u4e00\u65e6\u8d77\u6548\u53ef\u80fd\u70ba\u60a3\u8005\u5e36\u4f86\u9577\u671f\u751f\u5b58\u3002\u671f\u5f85tifcemalimab\u5728\u5f8c\u7e8c\u7814\u7a76\u4e2d\u7684\u8868\u73fe\uff0c\u70ba\u66f4\u591a\u6dcb\u5df4\u7624\u60a3\u8005\u5e36\u4f86\u65b0\u9078\u64c7\uff01\u201d<\/strong><\/p>\n\n\n\n \u541b\u5be6\u751f\u7269\u5168\u7403\u7814\u767c\u7e3d\u88c1\u9112\u5efa\u8ecd\u535a\u58eb<\/strong>\u8868\u793a\uff1a\u201c\u4f5c\u70ba\u4e00\u6b3e\u2018\u5168\u7403\u65b0\u2019\u85e5\u7269\uff0ctifcemalimab\u5728\u65e9\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\u986f\u793a\u51fa\u7684\u5b89\u5168\u6027\u548c\u7642\u6548\u4ee4\u4eba\u671f\u5f85\u3002\u7279\u5225\u662f\u6b64\u6b21ASH\u5e74\u6703\u4e0a\u767c\u8868\u7684\u66f4\u65b0\u8cc7\u6599\uff0c\u66f4\u7a81\u986f\u51fatifcemalimab\u8207\u7279\u745e\u666e\u5229\u55ae\u6297\u7684\u96d9\u514d\u75ab\u7642\u6cd5\u6cbb\u7642\u5c0d\u65bc\u6297PD-1\u55ae\u6297\u8010\u85e5\u7684\u5fa9\u767c\u6216\u96e3\u6cbb\u6027\u6dcb\u5df4\u7624\u60a3\u8005\u9817\u5177\u524d\u666f\uff0c\u503c\u5f97\u9032\u4e00\u6b65\u8a55\u4f30\u3002\u6b64\u5916\uff0c\u6211\u5011\u5728\u5be6\u9ad4\u7624\u60a3\u8005\u4e2d\u4e5f\u770b\u5230\u4e86\u9019\u9805\u806f\u5408\u65b9\u6848\u7a81\u51fa\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff0c\u671f\u5f85\u5728\u5f8c\u7e8c\u958b\u5c55\u7684\u7814\u7a76\u4e2d\u5f97\u5230\u9032\u4e00\u6b65\u9a57\u8b49\u3002\u201d<\/p>\n\n\n\n \u4eca\u5e746\u6708\uff0ctifcemalimab\u5728\u7f8e\u570b\u81e8\u5e8a\u816b\u7624\u5b78\u6703\uff08ASCO\uff09\u5e74\u6703\u4e0a\u9996\u6b21\u5c55\u793a\u4e86\u7528\u65bc\u6dcb\u5df4\u7624\u8207\u5be6\u9ad4\u7624\u6cbb\u7642\u7684\u65e9\u671f\u81e8\u5e8a\u6210\u679c\uff0c\u6210\u70baBTLA\u9776\u9ede\u85e5\u7269\u5728\u816b\u7624\u9818\u57df\u91cd\u8981\u7684\u91cc\u7a0b\u7891\u4e8b\u4ef6\u3002\u672c\u6b21\u5728ASH\u5e74\u6703\u4e0a\u516c\u4f48\u7684\u662f\u5176\u6dcb\u5df4\u7624\u7814\u7a76\u7684\u66f4\u65b0\u7d50\u679c\u3002\u9019\u9805\u55ae\u81c2\u3001\u958b\u653e\u6a19\u7c64\u3001\u591a\u4e2d\u5fc3\u3001\u5291\u91cf\u905e\u589eI\u671f\u7814\u7a76\uff08NCT04477772\uff09\uff0c\u9996\u6b21\u8a55\u4f30\u4e86tifcemalimab\u55ae\u85e5\u6216\u806f\u5408\u7279\u745e\u666e\u5229\u55ae\u6297\uff08\u6297PD-1\u55ae\u6297\uff09\u5728\u5fa9\u767c\u6216\u96e3\u6cbb\u6027\u6dcb\u5df4\u7624\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u4e3b\u8981\u7814\u7a76\u8005\u662f\u4f86\u81ea\u54c8\u723e\u6ff1\u8840\u6db2\u75c5\u816b\u7624\u7814\u7a76\u6240\u7684\u99ac\u8ecd\u6559\u6388\u548c\u5317\u4eac\u5927\u5b78\u816b\u7624\u91ab\u9662\u7684\u6731\u8ecd\u6559\u6388\uff0c\u7531\u5b8b\u7389\u7434\u6559\u6388\u4f5c\u70ba\u7814\u7a76\u5c55\u793a\u4f5c\u8005\u3002<\/p>\n\n\n\n \u622a\u81f32022\u5e7410\u670826\u65e5\uff0c\u7814\u7a76\u5171\u7d0d\u516563\u4f8b\u5fa9\u767c\u6216\u96e3\u6cbb\u6027\u6dcb\u5df4\u7624\u60a3\u8005\uff0c\u5305\u62ec43\u4f8b\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08HL\uff09\u60a3\u8005\u548c20\u4f8b\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08NHL\uff09\u60a3\u8005\u3002\u5176\u4e2d\uff0c\u55ae\u85e5\u6cbb\u7642\u7d4425\u4eba\uff0c\u5305\u62ec\u55ae\u85e5\u5291\u91cf\u905e\u589e\u90e8\u52069\u4eba\uff0c\u55ae\u85e5\u5291\u91cf\u64f4\u5c55\u90e8\u520616\u4eba\uff0c\u806f\u5408\u6cbb\u7642\u7d4438\u4eba\uff0c\u5305\u62ec\u806f\u5408\u5291\u91cf\u905e\u589e\u90e8\u52066\u4eba\uff0c\u806f\u5408\u5291\u91cf\u64f4\u5c55\u90e8\u520632\u4eba\u3002\u7d0d\u5165\u60a3\u8005\u5148\u524d\u6cbb\u7642\u7dda\u7684\u4e2d\u4f4d\u6578\u70ba4\uff0c\u5176\u4e2d73%\uff0846\u4f8b\uff09\u7684\u60a3\u8005\u66fe\u63a5\u53d7\u904e\u6297PD-1\/L1\u6297\u9ad4\u6cbb\u7642\u3002<\/p>\n\n\n\n \u5728\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u65b9\u9762\uff0c\u622a\u81f3\u8cc7\u6599\u622a\u81f3\u65e5\uff0c\u7814\u7a76\u5728\u55ae\u85e5\u6cbb\u7642\u548c\u806f\u5408\u6cbb\u7642\u7684\u5291\u91cf\u905e\u589e\u90e8\u5206\u5747\u672a\u89c0\u5bdf\u5230\u5291\u91cf\u9650\u5236\u6027\u6bd2\u6027\uff08DLT\uff09\u3002\u4e26\u4e14\uff0c\u806f\u5408\u6cbb\u7642\u7d44\u7684\u514d\u75ab\u76f8\u95dc\u4e0d\u826f\u4e8b\u4ef6\uff08irAE\uff09\u7279\u5fb5\u8207\u7279\u745e\u666e\u5229\u55ae\u6297\u55ae\u85e5\u6cbb\u7642\u6642\u4e00\u81f4\uff0c\u5728\u806f\u5408\u6cbb\u7642\u4f47\u5217\u4e2d\u672a\u767c\u73fe\u65b0\u7684\u5b89\u5168\u4fe1\u865f\u3002<\/p>\n\n\n\n \u5728\u81e8\u5e8a\u6297\u816b\u7624\u6d3b\u6027\u65b9\u9762\uff0c\u622a\u81f3\u8cc7\u6599\u622a\u81f3\u65e5\uff08\u4e2d\u4f4d\u5143\u96a8\u8a2a\u6642\u959329.1\u5468\uff09\uff0c\u5728\u55ae\u85e5\u6cbb\u7642\u7d44\u768425\u4f8b\u53ef\u8a55\u4f30\u60a3\u8005\u4e2d\u89c0\u5bdf\u52301\u4f8b\uff08\u6ffe\u6ce1\u6027\u6dcb\u5df4\u7624\uff09\u90e8\u5206\u7de9\u89e3\uff08PR\uff09\u548c7\u4f8b\u75be\u75c5\u7a69\u5b9a\uff08SD\uff09\u3002\u5728\u806f\u5408\u6cbb\u7642\u7d44\u768428\u4f8b\u53ef\u8a55\u4f30\u60a3\u8005\u4e2d\uff0c85.7%\uff0824\u4f8b\uff09\u70ba\u63a5\u53d7\u6297PD-1\u6297\u9ad4\u6cbb\u7642\u5f8c\u9032\u5c55\u7684\u60a3\u8005\uff0c\u89c0\u5bdf\u52301\u4f8b\u5b8c\u5168\u7de9\u89e3\uff08CR\uff09\u300110\u4f8bPR\u548c13\u4f8bSD\uff0c\u5ba2\u89c0\u7de9\u89e3\u7387\uff08ORR\uff09\u9054\u523039.3%\uff0c\u75be\u75c5\u63a7\u5236\u7387\uff08DCR\uff09\u9054\u523085.7%\u3002\u806f\u5408\u6cbb\u7642\u7d44\u4e2d\u6240\u6709\u7de9\u89e3\u60a3\u8005\uff08CR\/PR\uff09\u4e2d\u4f4d\u6301\u7e8c\u7de9\u89e3\u6642\u9593\u4ecd\u672a\u6210\u719f\u3002<\/p>\n\n\n\n <\/p>\n\n\n\n <\/p>\n\n\n\n\n\n \u95dc\u65bctifcemalimab\uff08TAB004\/JS004\uff09<\/strong><\/p>\n\n\n\n Tifcemalimab\uff08TAB004\/JS004\uff09\u662f\u541b\u5be6\u751f\u7269\u81ea\u4e3b\u7814\u767c\u7684\u5168\u7403\u9996\u500b\u9032\u5165\u81e8\u5e8a\u958b\u767c\u968e\u6bb5\uff08first-in-human\uff09\u7684\u6297\u816b\u7624\u91cd\u7d44\u4eba\u6e90\u5316\u6297BTLA\uff08B\u548cT\u6dcb\u5df4\u7d30\u80de\u8870\u6e1b\u56e0\u6578\uff09\u55ae\u514b\u9686\u6297\u9ad4\u3002\u76ee\u524d\uff0ctifcemalimab\u5df2\u9032\u5165Ib\/II\u671f\u81e8\u5e8a\u7814\u7a76\u968e\u6bb5\uff0c\u591a\u9805\u806f\u5408\u7279\u745e\u666e\u5229\u55ae\u6297\u7684\u81e8\u5e8a\u7814\u7a76\u6b63\u5728\u4e2d\u570b\u548c\u7f8e\u570b\u540c\u6b65\u958b\u5c55\u4e2d\uff0c\u8986\u84cb\u591a\u500b\u7624\u7a2e\u3002<\/p>\n\n\n\n Tifcemalimab\u6240\u91dd\u5c0d\u7684BTLA\u9776\u9ede\u65bc2003\u5e74\u767c\u73fe\uff0c\u70baCD28\u53d7\u9ad4\u5bb6\u65cf\u6210\u54e11<\/sup>\u3002\u5b83\u5177\u6709\u55ae\u500bIgSF V\u7d30\u80de\u5916\u57df\uff0c\u5176\u5e8f\u5217\u8207\u5176\u4ed6CD28\u5bb6\u65cf\u5206\u5b50\uff08\u4f8b\u5982PD-1\u548cCTLA-4\uff09\u5177\u6709\u76f8\u4f3c\u6027\u3002<\/p>\n\n\n\n BTLA\u5728T\u548cB\u6dcb\u5df4\u7d30\u80de\u4ee5\u53ca\u6a39\u7a81\u72c0\u7d30\u80de\u4e9e\u7fa4\u4e0a\u8868\u9054\u3002BTLA\u8207\u5176\u914d\u9ad4HVEM\uff08Herpes virus entry mediator\uff0c\u76b0\u75b9\u75c5\u6bd2\u4fb5\u5165\u4ecb\u8cea\uff09\u7684\u76f8\u4e92\u4f5c\u7528\u65bc2005\u5e74\u88ab\u767c\u73fe\uff0cHVEM\u662f\u5728\u9020\u8840\u7cfb\u7d71\u4e2d\u5ee3\u6cdb\u8868\u9054\u7684TNF\u53d7\u9ad4\uff0c\u88ab\u78ba\u5b9a\u70baBTLA\u7684\u914d\u9ad42<\/sup>\u3002<\/p>\n\n\n\n BTLA\u662f\u4e00\u7a2e\u514d\u75ab\u7403\u86cb\u767d\u76f8\u95dc\u6027\u819c\u86cb\u767d\uff0c\u5176\u86cb\u767d\u7d50\u69cb\u985e\u4f3c\u65bc\u8de8\u819c\u53d7\u9ad4CTLA-4\u548cPD-1\u3002\u5728\u6b63\u5e38\u751f\u7406\u60c5\u6cc1\u4e0b\uff0cBTLA\u8207\u5176\u914d\u9ad4HVEM\u7d50\u5408\u5f8c\uff0c\u53ef\u4ee5\u6291\u5236\u6dcb\u5df4\u7d30\u80de\u7684\u904e\u5ea6\u6d3b\u5316\uff0c\u9632\u6b62\u514d\u75ab\u7cfb\u7d71\u5c0d\u81ea\u8eab\u7684\u640d\u50b72<\/sup>\u3002<\/p>\n\n\n\n Tifcemalimab\u901a\u904e\u7d50\u5408BTLA\uff0c\u963b\u65b7HVEM-BTLA\u7684\u76f8\u4e92\u4f5c\u7528\uff0c\u5f9e\u800c\u963b\u65b7BTLA\u4ecb\u5c0e\u7684\u6291\u5236\u6027\u4fe1\u865f\u901a\u8def\uff0c\u6700\u7d42\u9054\u5230\u555f\u52d5\u816b\u7624\u7279\u7570\u6dcb\u5df4\u7d30\u80de\u7684\u4f5c\u7528\u3002<\/p>\n\n\n\n <\/p>\n\n\n","protected":false},"excerpt":{"rendered":" \u5317\u4eac\u6642\u95932022\u5e7412\u670811\u65e5\uff0c\u541b\u5be6\u751f\u7269\uff081877.HK\uff0c688180.SH\uff09\u5ba3\u4f48\uff0c\u7531\u516c\u53f8\u81ea\u4e3b\u7814\u767c\u7684\u5168\u7403\u9996\u500b\u9032\u5165\u81e8\u5e8a\u968e\u6bb5\u7684\u6297\u816b\u7624\u6297BTLA\u55ae\u6297tifcemalimab\uff08TAB004\/JS004\uff09\u57282022\u5e74\u7b2c64\u5c46\u7f8e\u570b\u8840\u6db2\u5b78\u6703\uff08ASH\uff09\u5e74\u6703\u4e0a\u4ee5\u58c1\u5831\u5f62\u5f0f\uff08#1613\uff09\u66f4\u65b0\u4e86\u5176\u5728\u5fa9\u767c\u6216\u96e3\u6cbb\u6027\u6dcb\u5df4\u7624\u60a3\u8005\u4e2d\u9032\u884c\u7684I\u671f\u81e8\u5e8a\u8a66\u9a57\u521d\u6b65\u8cc7\u6599\u3002<\/p>\n","protected":false},"author":3,"featured_media":1140,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21],"tags":[],"class_list":["post-571","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-21"],"yoast_head":"\n1. <\/em>\u672c\u6750\u6599\u65e8\u5728\u50b3\u905e\u524d\u6cbf\u8cc7\u8a0a\uff0c\u7121\u610f\u5411\u60a8\u505a\u4efb\u4f55\u7522\u54c1\u7684\u63a8\u5ee3\uff0c\u4e0d\u4f5c\u70ba\u81e8\u5e8a\u7528\u85e5\u6307\u5c0e\u3002<\/em><\/em><\/h6>\n\n\n\n
2. <\/em>\u82e5\u60a8\u60f3\u77ad\u89e3\u5177\u9ad4\u75be\u75c5\u8a3a\u7642\u8cc7\u8a0a\uff0c\u8acb\u9075\u5f9e\u91ab\u7642\u885b\u751f\u5c08\u696d\u4eba\u58eb\u7684\u610f\u898b\u8207\u6307\u5c0e\u3002<\/em><\/em><\/h6>\n\n\n\n
\u3010\u53c3\u8003\u6587\u737b\u3011<\/h5>\n\n\n\n
[1] Watanabe, N., Gavrieli, M., Sedy, J.R., Yang,J., Fallarino, F., Loftin, S.K., Hurchla, M.A., Zimmerman, N., Sim, J., Zang, X., et al. (2003). BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 4, 670-679.<\/h5>\n\n\n\n
[2] Sedy, J.R., Gavrieli, M., Potter, K.G., Hurchla, M.A., Lindsley, R.C., Hildner, K., Scheu, S., Pfeffer, K., Ware, C.F., Murphy, T.L., et al. (2005). B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 6, 90-98.<\/h5>\n\n\n\n